FDA drug recalls
Formal FDA enforcement reports for prescription and over-the-counter drugs — contamination, wrong potency, mislabeling, and manufacturing failures. 341 recalls in the last 12 months, in plain English.
Recent recalls
Page 11 of 12- Stop using AvKARE Rosuvastatin 10 mg tablets
AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.
ModerateFDAJan 14, 2026AvKARE
- MediNatura ReBoost and ClearLife nasal sprays recalled for contamination
MediNatura is recalling two nasal sprays: ReBoost Nasal Spray and ClearLife Allergy Nasal Spray, Extra Strength, both in 20 mL bottles. FDA found yeast, mold and Achromobacter bacteria in the products, which are not sterile. No injuries have been reported.
SeriousFDAJan 14, 2026Medinatura2 products
- SpecGx oxycodone-acetaminophen tablets recalled for possible missing imprint
SpecGx LLC is recalling certain bottles of oxycodone and acetaminophen 10mg/325mg tablets because some tablets may be missing the imprint (marking). This could make it difficult to identify the medication. No injuries have been reported.
ModerateFDAJan 14, 2026SpecGx2 products
- ORL Kids bubblegum mouthwash, toothpaste recalled for manufacturing quality issues
ORL Labs is recalling two ORL Kids bubblegum-flavored products: a 16.9 oz mouthwash and a 4 oz natural toothpaste. The products were not made under the required current good manufacturing practices, which are the quality standards for making drugs. The recall covers products distributed only in Arizona, and no injuries have been reported.
ModerateFDAJan 14, 2026Signature Formulations2 products
- Imprimis Dexamethasone-Moxifloxacin and Tri-Moxi+ recalled for glass particles
Imprimis is recalling three prefilled eye injection products because they may contain glass-like particles. The products are Dexamethasone Moxifloxacin, Dexamethasone Moxifloxacin Ketorolac, and Tri-Moxi+, with 1,688 affected boxes shipped nationwide. No injuries have been reported.
ModerateFDAJan 14, 2026Imprimis3 products
- Alembic fesoterodine tablets recalled for impurity level above limit
Alembic Pharmaceuticals is recalling one lot of Fesoterodine Fumarate 8 mg extended-release tablets because testing found levels of a chemical impurity (diester impurity) that exceed safety limits. The affected lot is 2405003360, which expires January 31, 2026.
ModerateFDAJan 14, 2026Alembic Pharmaceuticals
- Check your trazodone tablets for dents
Zydus Pharmaceuticals is recalling certain bottles of trazodone 100mg tablets because some tablets have dents on the surface. The defect affects lot EA00237A with an expiration date of 04/30/2027. No injuries have been reported.
FDAJan 7, 2026Zydus
- Glenmark ondansetron tablets recalled for unsealed blister packs
Glenmark Pharmaceuticals discovered that blister packs containing Ondansetron 4mg orally disintegrating tablets are not fully sealed, allowing tablets to fall out. The affected product was repackaged and distributed nationwide. This applies to lot #19251311 with an expiration date of April 2027.
ModerateFDAJan 7, 2026Glenmark
- Wegovy injection recalled for particulate matter
Novo Nordisk discovered hair in some prefilled Wegovy injection pens. This affects specific lot numbers manufactured in Denmark. No injuries have been reported.
ModerateFDAJan 7, 2026Novo Nordisk2 products
- Stop using BD ChloraPrep Triple Swabsticks
CareFusion 213, LLC is recalling BD ChloraPrep Triple Swabsticks (a skin antiseptic swab) because the manufacturer cannot confirm the product was properly sterilized. The affected lot (#5086623, expiring 3/31/2028) was distributed nationwide. No injuries have been reported.
ModerateFDAJan 7, 2026CareFusion
- Merck Emend and Noxafil Powdermix recalled for metal particulates
Merck is recalling two prescription medicines, Emend (aprepitant) for oral suspension 125 mg single-dose kits and Noxafil Powdermix (posaconazole) 300 mg packets, because they may contain metal particles. The recall covers 3 Emend kits and 845 Noxafil Powdermix kits, distributed nationwide. No injuries have been reported.
ModerateFDADec 31, 2025Merck2 products
- Sun Pharma/Taro ciclopirox shampoo recalled for impurity test failures
Taro Pharmaceuticals is recalling specific lots of Ciclopirox Shampoo 1% because the product failed quality tests for impurities and degradation at the 18-month mark. The affected lots expire January 31, 2026. No injuries have been reported.
ModerateFDADec 24, 2025Sun Pharmaceutical
- Preferred Pharmaceuticals ondansetron ODT recalled for unsealed blisters
Preferred Pharmaceuticals is recalling ondansetron ODT 4mg tablets because the blister pack containers are not fully sealed, which can cause tablets to fall out. The manufacturer Glenmark Pharmaceuticals notified Preferred Pharmaceuticals of the sealing defect. This affects specific lot numbers distributed nationwide.
ModerateFDADec 24, 2025Preferred Pharmaceuticals
- Somerset cisatracurium injection recalled for low potency
Somerset Therapeutics is recalling three cisatracurium besylate injection products because testing found the drug may be weaker than its label states. The recall covers 10 mg/5 mL, 200 mg/20 mL and 20 mg/10 mL vials, all made by Somerset Therapeutics in India and distributed nationwide. No injuries have been reported.
ModerateFDADec 24, 2025Somerset Therapeutics3 products
- Golden State Medical Supply baclofen recalled for foreign tablets
Golden State Medical Supply's baclofen 10 mg tablets in 1,000-count bottles (Lot GS065762) may contain foreign tablets or capsules mixed in. This affects 2,472 bottles distributed nationwide. No injuries have been reported.
ModerateFDADec 24, 2025Golden State Medical Supply
- Xylocaine, Polocaine and more dental anesthetic recalled for cracked cartridges
Novocol is recalling 7 dental anesthetic products because some cartridges may be cracked or broken. The products are sold under names including Xylocaine Dental, Polocaine Dental, Carbocaine, and OraVerse, plus private-label versions from Dentsply, Patterson Dental, darby dental supply, Benco Dental, and Cook-Waite. No injuries have been reported.
ModerateFDADec 24, 2025Novocol7 products
- Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
Defective container - seal not adhering to bottles
FDADec 17, 2025Lupin
- Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
FDADec 17, 2025Cipla3 products
- Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
FDADec 17, 2025Winder Laboratories
- Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Cross Contamination with Other Products
FDADec 17, 2025Glenmark
- Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
Incorrect Product Formulation
FDADec 17, 2025Fagron
- Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
FDADec 17, 2025Lupin
- Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
FDADec 17, 2025Dr. Reddy's
- Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
Failed stability specifications: Out of specification for hardness test
FDADec 17, 2025Cipla2 products
- Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
FDADec 10, 2025Breckenridge2 products
- Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health LLC KITCHECK RFID Tag attached with incorrect serial numbers: KITCHECK 8001-03A3,00000000,003A-2560, and 8001-03A3,00000000,003A-2D3B.
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
FDADec 10, 2025Safecor Health
- Dynashield, Nivagen, Globe and more recalled for quality issues
Blossom Pharmaceuticals is recalling 13 skin care and wound products over manufacturing quality problems, called cGMP deviations, that violate federal manufacturing rules. The products are sold under the Dynashield, Lanashield, Dynagel, WeCare, Nivagen and Globe names, and are distributed nationwide in the USA. No injuries have been reported.
ModerateFDADec 10, 2025Blossom Pharmaceuticals13 products
- Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
CGMP Deviations
FDADec 10, 2025Park Avenue Compounding
- Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430.
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
FDADec 10, 2025Glenmark
- Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.
Defective Container - A defect in the side-seal which allows leakage of product.
FDADec 10, 2025Teva